RAJNISH WELLNESS
|
RAJNISH WELLNESS Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.01 | 0.37 | 0.21 | -1.30 | 9.06 |
| CEPS(Rs) | 0.01 | 0.01 | - | -0.02 | 0.14 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 1.08 | 21.04 | 46.49 | 46.28 | 47.58 |
| Tax Rate(%) | 27.25 | 28.58 | 13.68 | 1.31 | 27.86 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -4.30 | -0.36 | -23.73 | 0.98 | 15.64 |
| EBIT Margin(%) | 2.59 | 3.15 | 3.14 | 1.98 | 16.20 |
| Pre Tax Margin(%) | 2.45 | 2.08 | 0.87 | -4.49 | 14.09 |
| PAT Margin (%) | 1.78 | 1.48 | 0.75 | -4.43 | 10.16 |
| Cash Profit Margin (%) | 1.83 | 1.51 | 1.16 | -4.04 | 10.32 |
| Performance Ratios | |||||
| ROA(%) | 0.69 | 1.13 | 0.29 | -1.88 | 17.18 |
| ROE(%) | 0.88 | 1.79 | 0.46 | -2.78 | 29.97 |
| ROCE(%) | 1.08 | 2.71 | 1.40 | 0.97 | 36.75 |
| Asset Turnover(x) | 0.39 | 0.76 | 0.39 | 0.42 | 1.69 |
| Sales/Fixed Asset(x) | 89.27 | 102.07 | 54.60 | 56.54 | 202.06 |
| Working Capital/Sales(x) | 0.95 | 0.93 | 0.50 | 0.52 | 1.86 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.01 | 0.01 | 0.02 | 0.02 | - |
| Receivable days | 257.12 | 227.79 | 393.83 | 407.72 | 141.95 |
| Inventory Days | 41.29 | 22.06 | 29.23 | 52.81 | 22.17 |
| Payable days | 36.48 | 24.50 | 39.84 | 51.68 | 67.79 |
| Valuation Parameters | |||||
| PER(x) | 2,766.67 | 7.50 | 0.78 | - | 0.24 |
| PCE(x) | 2,699.26 | 221.43 | 33.86 | -15.68 | 16.19 |
| Price/Book(x) | 15.37 | 3.99 | 0.24 | 0.40 | 3.13 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 49.78 | 3.64 | 1.03 | 1.19 | 1.75 |
| EV/Core EBITDA(x) | 1,884.64 | 114.66 | 28.90 | 50.30 | 10.68 |
| EV/EBIT(x) | 1,919.82 | 115.51 | 32.73 | 60.09 | 10.78 |
| EV/CE(x) | 13.00 | 2.75 | 0.40 | 0.49 | 2.29 |
| M Cap / Sales | 49.39 | 3.34 | 0.39 | 0.63 | 1.67 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -2.31 | 98.16 | -2.95 | -67.01 | 51.54 |
| Core EBITDA Growth(%) | -18.76 | 76.80 | 46.14 | -95.23 | 53.02 |
| EBIT Growth(%) | -19.65 | 98.76 | 54.14 | -95.97 | 53.39 |
| PAT Growth(%) | 17.37 | 293.18 | 116.38 | -114.37 | 74.00 |
| EPS Growth(%) | -98.39 | 74.75 | 116.38 | -114.37 | 27.04 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.12 | 0.41 | 0.40 | 0.36 | 0.21 |
| Current Ratio(x) | 3.58 | 5.81 | 4.90 | 5.48 | 3.51 |
| Quick Ratio(x) | 3.22 | 5.46 | 4.74 | 5.30 | 3.18 |
| Interest Cover(x) | 18.00 | 2.93 | 1.38 | 0.31 | 7.69 |
| Total Debt/Mcap(x) | 0.01 | 0.10 | 1.64 | 0.88 | 0.07 |
Compare Financial Ratios of peers of RAJNISH WELLNESS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RAJNISH WELLNESS | ₹512.6 Cr | -6.3% | -11.8% | -49.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 1.6% | -3.7% | 60% | Stock Analytics | |
| CIPLA | ₹109,559.0 Cr | -2% | -4.6% | 49.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹103,416.0 Cr | -0.9% | 4.2% | 14.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,088.9 Cr | -2.1% | -0.9% | 89.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,939.0 Cr | -3.1% | -4.7% | 21.6% | Stock Analytics | |
RAJNISH WELLNESS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RAJNISH WELLNESS | -6.3% |
-11.8% |
-49.8% |
| SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses
